Skip to main content
. 2023 Feb 6;11(2):e005267. doi: 10.1136/jitc-2022-005267

Figure 3.

Figure 3

Peripheral TGF-β, CD73 TO, and sCD73 levels across all dalutrafusp alfa cohorts. (A) TGF-β1 in plasma on-treatment with dalutrafusp alfa. (B) CD73 TO on B cells in whole blood on-treatment with dalutrafusp alfa. (C) Free sCD73 in plasma on-treatment with dalutrafusp alfa. (D) sCD73 activity in plasma on-treatment with dalutrafusp alfa. CD, cluster of differentiation; s, soluble; TGF, tumor growth factor; TO, target occupancy.